InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,018.39
(
-0.34%
)
US TECH 100
16,878.40
(
-0.62%
)
Dow Jones
37,903.29
(
0.23%
)
Brent Oil
83.54
(
-2.75%
)
Bitcoin
57,401.61
(
-5.28%
)
Post# of 251666
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

goodJohnhunting

Send PM Follow Ignore
Followers 35
Posts 1202
Boards Moderated 1
Alias Born 08/27/2000

goodJohnhunting

Member Level

Re: pcrutch post# 173473

Thursday, 01/30/2014 6:33:45 PM

Thursday, January 30, 2014 6:33:45 PM

Post# of 251666
From the case study you provided.

However, two executive function component tests of the NTB showed significant improvement over placebo in the PBT2 250 mg group from baseline to week 12



What this means is that dementia may share pathophysiological mechanisms. PBT2 appears to be multi-fuctional in this regard, (reduction in amyloid deposits and neural regeneration).

I'm hopeful for something therapeutic in this arena, but not getting to excited here. However, I'm grateful for the opportunity to make money on the ride from $2 to $13 :) Playing house money now.

How bout you?

All the best,
John



Disclaimer: Every post, and all my views are only speculative. Do not invest money or any other resources based on these post or opinions. Best of luck and do your own due diligence!

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up